Rights and permissions
About this article
Cite this article
HAART introduction in Italy provides cost, QOL advantage. Pharmacoecon. Outcomes News 445, 9 (2004). https://doi.org/10.2165/00151234-200404450-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404450-00015